Key result
African swine fever vaccine development remains challenging due to poor inactivated protection and live-attenuated risks.
Why the study?
Vaccination is the optimal strategy to prevent and control African swine fever, but an effective vaccine with high immunoprotective potential remains to be explored.
Design
Review
Authors
Loading...
Prioritizes novel ASF vaccine platforms; leaves open which candidates will achieve safe, durable protection.
Developing a safe and effective ASFV vaccine remains a critical global priority to control the devastating economic losses in the swine industry, with current research focusing on overcoming the safety and efficacy limitations of existing vaccine candidates.
Zhang et al. (2023) conducted a review in African swine fever. African swine fever vaccines was evaluated. Developing a safe and effective African swine fever vaccine remains challenging due to poor immune protection of inactivated vaccines and safety concerns of live attenuated vaccines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: